ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,244,000 | -9.3% | 100,000 | -0.2% | 0.85% | +9.7% |
| Q3 2016 | $1,372,000 | +3.4% | 100,250 | -44.2% | 0.78% | +3.3% |
| Q2 2016 | $1,327,000 | +16.5% | 179,515 | +0.7% | 0.75% | +1.6% |
| Q1 2016 | $1,139,000 | +11.4% | 178,265 | +9.0% | 0.74% | +40.0% |
| Q4 2015 | $1,022,000 | -58.6% | 163,515 | -61.3% | 0.53% | -51.6% |
| Q3 2015 | $2,469,000 | -27.7% | 422,765 | +2.4% | 1.09% | -22.6% |
| Q2 2015 | $3,414,000 | +157.5% | 412,765 | +156.5% | 1.41% | +130.4% |
| Q1 2015 | $1,326,000 | +157.5% | 160,915 | +114.8% | 0.61% | +161.1% |
| Q4 2014 | $515,000 | – | 74,915 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |